francine blumental de abreu - PHL © Elysio - FUNDAÇÃO ANTÔNIO ...

235
Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg
Oncol. 2000; 18:305-13.
Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic
heterogeneity in the Lynch syndrome: diagnostic, surveillance and
management implications. Eur J Hum Genet 2006; 14:390-402.
Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review
of the Lynch syndrome: history, molecular genetics, screening, differential
diagnosis, and medicolegal ramifications. Clin Genet 2009; 76:1-18.
MacDonald DJ. Germline mutations in cancer susceptibility genes: an
overview for nurses. Semin Oncol Nurs 2011; 27:21-33.
Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N/A)
transporters of the SLC38 gene family. Pflugers Arch 2004; 447:784-95.
Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in
cancer. Nat Rev Cancer 2001; 1:222-31.
Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance
susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of
BRCA1 or BRCA2 mutations. Nat Genet 2002; 31:55-9.
Meijers-Heijboer H, Wijnen J, Vasen H, et al. The CHEK2 1100delC mutation
identifies families with a hereditary breast and colorectal cancer phenotype.
Am J Hum Genet 2003; 72:1308-14.
Meyerson M, Enders GH, Wu CL, et al. A family of human cdc2-related
protein kinases. EMBO J 1992; 11:2909-17.